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Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia
TO THE EDITOR
The t(12;21)(p13;q22) translocation is the most frequent chromosomal abnormality associated with pediatric B cell precursor acute lymphoblastic leukemia (ALL). The translocation partners are the TEL and AML1 genes on chromosome 12 and 21, respectively. The majority of t(12;21) translocations occur in TEL intron 5 and AML1 intron 1, resulting in fusion of TEL exons 1-5 and AML1 exons 2-8. 1 The rearrangement process involved in the translocations has been explained by mistakes in normal V(D)J recombinase activity, homologous recombination between repeated sequences or fusion between staggered double-strand DNA. We have conducted analyses of the chromosomal breakpoint regions in DNA from nine ALL patients carrying the t(12;21) translocation to describe the molecular mechanisms of the rearrangement process.
The source of DNA was mononuclear cells isolated by Ficoll density centrifugation from peripheral blood or bone marrow at the time of diagnosis. Genomic DNA was isolated using a standard SDS/proteinase K/phenol extraction method. To identify the breakpoint regions, we performed long distance inverse PCR (LDI-PCR) analyses essentially as described by Willis et al 2 using the Expand 20 kb plus PCR System (Roche, Mannheim, Germany) and primers described by Wiemels et al. 1 PCR conditions were: 92°C for 2 min; 30 cycles of: (92°C for 10 s; 62°C for 30 s; 68°C for 14 min) and 68°C for 7 min. PCR products were extracted using phenol:chloroform (pH 8.0) and the DNA sequence determined.
Five TEL-AML1 translocations were identified (patients 1, 3, 4, 7 and 9) using intra-ligated BamHI-digested genomic DNA and various combinations of inverse PCR primers situated in TEL. The presence of AML1 (and TEL) in the LDI-PCR products were verified by sequence determination. When translocations were not identified using BamHI, the procedure was repeated using EcoRI or HindIII digestions. EcoRI identified three (patients 5, 6 and 8) and HindIII one (patient 2) translocations.
The reciprocal breakpoint regions were identified either by LDI-PCR or by conventional PCR using nested primers encompassing the predicted AML1-TEL boundary region of each patient. These theoretical boundary regions were based on database-generated sequences fusing AML1 and TEL at the position of the TEL-AML1 translocation found in each patient. Apparently, the reciprocal fusion gene, ie AML1-TEL, is transcribed only in a subset of t(12;21) ALL leukemias. 3 Consistent with this observation, we identified the AML1-TEL fusion gene in only four out of nine patients (patients 3, 5, 6 and 9). This could be explained by loss of the reciprocal translocation or by large deletions in the breakpoint region of TEL-AML1 or in the reciprocal AML1-TEL. The latter will interfere with our PCR-based detection methods as the binding sequence of one or both primers may have been deleted.
By alignment of the breakpoint region sequences and Genbank entries containing TEL and AML1 sequences, we identified microhomologies, deletions, insertions and duplications in several breakpoint regions (Figure 1 ). In seven of nine patients, we observed short regions of microhomology spanning 1-6 nucleotides in the TEL and AML1 genes at the site of recombination. Two patients (3 and 6) had deletions of both TEL and AML1 sequences, ie, there was a gap between the last TEL nucleotide of TEL-AML1 and the first TEL nucleotide of AML1-TEL when compared to TEL database sequences, and vice versa for AML1. Duplication of AML1 sequence was observed in patient 9: the first 99 bp of AML1 sequence situated in the TEL-AML1 breakpoint region were identical to the last 99 bp of AML1 sequence in the breakpoint region of the AML1-TEL fusion gene. In the AML1-TEL breakpoint junction of patient 6 was an insert of 293 bp, unrelated to both TEL and AML1 sequences. Using the HighThroughput Genomic Sequences database (http://www. ncbi.nlm.nih.gov), this 293 bp fragment was allocated to chromosome 8. In patient 7, the AML1 sequence was inverted relative to the direction seen in the other patients. Since the RT-PCR product showed no abnormalities compared to the RT-PCR products of other t(12;21) patients (data not shown), this may be an example of an inversion in the AML1 intronic sequence.
Illegitimate V(D)J rearrangements or Alu-mediated homologous recombination has been proposed as possible mechanisms in chromosomal rearrangements. 4, 5 We found 5/7 and 6/7 matches to the V(D)J heptamer sequence in close proximity to the breakpoints in all the patients, but only two 7/9 matches to the nonamer signal sequence (patients 4 and 7). In patients 1, 2, 4, 5 and 8 the 5/7 or 6/7 matches were identified only in the AML1 sequence. The insertion of Nnucleotides has been explained by terminal deoxynucleotidyl transferase (TdT) activity in cells undergoing V(D)J rearrangements. 6 We observed insertion of N-nucleotides in three cases (patients 5, 6 and 9). Repeat sequences (all different from Alu repeats) were identified in two AML1 breakpoint regions (patients 1 and 3) and one TEL breakpoint region (patient 6) using the NIX repeat region prediction program (http://www.hgmp.mrc.ac.uk). Based on these observations, we conclude that neither illegitimate V(D)J rearrangements nor repeat region-mediated homologous recombination were generally involved in the t(12;21) translocations. It has been suggested that double-strand DNA breaks and DNA repair mechanisms might be responsible for generating translocations. 7 In agreement with this, we found microhomologies, duplications and deletions at the breakpoint junctions of several patients. Furthermore, we found that the breakpoints in TEL-AML1 were distributed randomly and not clustered, as suggested in previous reports. 1, 3 The AML1 breakpoint of patient 6 was positioned in intron 2 unlike the breakpoints of the other patients. There was no apparent difference in the leukemic phenotype between patient 6 and the other patients. Indeed, the first two exons of AML1 are not believed to encode any significant functional features. 8 We performed a reporter transcription assay to describe a putative difference in the transcriptional regulating potential of TEL-AML1 fusion proteins with or without AML1 exon 2. The result obtained from this model system further supported the notion that AML1 exon 2 does not affect the transcriptional regulating potential of the fusion protein (data not shown).
Our observations favor the hypothesis that double-strand DNA breaks and a DNA repair mechanism such as nonhomologous end joining are involved in t(12;21) translocations, rather than specific recombinase activity. 7 However, more extensive studies of chromosomal breakpoint regions are needed in order to establish one or more precise mechanisms responsible for these chromosomal disorders.
Figure 1
Sequences of the TEL-AML1 and AML1-TEL (when available) breakpoint regions. Homology between individual nucleotides of the breakpoint region sequences and database sequences of TEL and AML1 are illustrated by vertical bars. Nucleotides printed in bold represent microhomologies between TEL and AML1 nucleotides at the site of recombination, underlined sequences are 5/7 and 6/7 matches to the heptamer sequence of the V(D)J recombination machinery (CACA/TGTG), and ++ indicate 7/9 matches to the nonamer sequence of the V(D)J recombination machinery (ACAAAAACC). The * in the AML1-TEL fusion sequence of patient 6 represents the 293 bp of chromosome 8 inserted in the breakpoint junction.
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